137 related articles for article (PubMed ID: 6606394)
1. Susceptibility of 40 Haemophilus ducreyi strains to 34 antimicrobial products.
Slootmans L; Vanden Berghe DA; Van Dyck E; Piot P
Antimicrob Agents Chemother; 1983 Oct; 24(4):564-7. PubMed ID: 6606394
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.
Dangor Y; Miller SD; Exposto Fda L; Koornhof HJ
Antimicrob Agents Chemother; 1988 Sep; 32(9):1458-60. PubMed ID: 3264133
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of Haemophilus ducreyi.
Hammond GW; Lian CJ; Wilt JC; Ronald AR
Antimicrob Agents Chemother; 1978 Apr; 13(4):608-12. PubMed ID: 307364
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand.
Taylor DN; Echeverria P; Hanchalay S; Pitarangsi C; Slootmans L; Piot P
J Clin Microbiol; 1985 Mar; 21(3):442-4. PubMed ID: 3872313
[TBL] [Abstract][Full Text] [Related]
5. In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.
Sanson-Le Pors MJ; Casin I; Ortenberg M; Perol Y
J Antimicrob Chemother; 1983 Mar; 11(3):271-80. PubMed ID: 6601649
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
Ismaeel NA
Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Etest with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi.
Lagergård T; Frisk A; Trollfors B
J Antimicrob Chemother; 1996 Nov; 38(5):849-52. PubMed ID: 8961054
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.
Sanson-Le Pors MJ; Casin IM; Thebault MC; Arlet G; Perol Y
Antimicrob Agents Chemother; 1986 Sep; 30(3):512-3. PubMed ID: 2946262
[TBL] [Abstract][Full Text] [Related]
9. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.
Motley M; Sarafian SK; Knapp JS; Zaidi AA; Schmid G
Antimicrob Agents Chemother; 1992 Aug; 36(8):1639-43. PubMed ID: 1416845
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Haemophilus ducreyi to ampicillin and sulbactam in vitro.
Jones BM; Hafiz S; Duerden BI
Antimicrob Agents Chemother; 1986 Jun; 29(6):1110-2. PubMed ID: 3015016
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.
Bilgeri YR; Ballard RC; Duncan MO; Mauff AC; Koornhof HJ
Antimicrob Agents Chemother; 1982 Oct; 22(4):686-8. PubMed ID: 6983858
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Haemophilus ducreyi to spectinomycin in vitro.
Hafiz S; Jones BM; Kinghorn GR; Duerden BI
Genitourin Med; 1986 Aug; 62(4):251-2. PubMed ID: 2942458
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Haemophilus ducreyi. A study.
Sng EH; Lim AL; Rajan VS; Goh AJ
Br J Vener Dis; 1982 Aug; 58(4):239-42. PubMed ID: 6980682
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antimicrobial susceptibility patterns of fifty-seven strains of Haemophilus ducreyi isolated in Amsterdam from 1978 to 1985.
Sturm AW
J Antimicrob Chemother; 1987 Feb; 19(2):187-91. PubMed ID: 3494720
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
[TBL] [Abstract][Full Text] [Related]
16. Assessing the antibiotic potential of essential oils against Haemophilus ducreyi.
Lindeman Z; Waggoner M; Batdorff A; Humphreys TL
BMC Complement Altern Med; 2014 May; 14():172. PubMed ID: 24885682
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.
Aldridge KE; Cammarata C; Martin DH
Antimicrob Agents Chemother; 1993 Sep; 37(9):1986-8. PubMed ID: 8239617
[TBL] [Abstract][Full Text] [Related]
18. Haemophilus ducreyi is resistant to human antimicrobial peptides.
Mount KL; Townsend CA; Bauer ME
Antimicrob Agents Chemother; 2007 Sep; 51(9):3391-3. PubMed ID: 17620373
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activity of combination antimicrobial agents on Haemophilus ducreyi.
Roy-Leon JE; Lauzon WD; Toye B; Singhal N; Cameron DW
J Antimicrob Chemother; 2005 Sep; 56(3):552-8. PubMed ID: 16046468
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa.
Abeck D; Johnson AP; Dangor Y; Ballard RC
J Antimicrob Chemother; 1988 Oct; 22(4):437-44. PubMed ID: 3264554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
